A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience

INTRODUCTION: Fibromyalgia is a neuropathic syndrome which is more common in adult females. Pregabalin is the first medicine which was approved by the United States Food and Drug Administration for treatment of fibromyalgia. In this study we aimed to evaluate the cost-efficacy of pregabalin in the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshavarz, Khosro, Hashemi-Meshkini, Amir, Gharibnaseri, Zahra, Nikfar, Shekoufeh, Kebriaeezadeh, Abbas, Abdollahi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2013
Materias:
Systematic review/Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902716/
https://www.ncbi.nlm.nih.gov/pubmed/24482637
http://dx.doi.org/10.5114/aoms.2013.39617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902716/
https://www.ncbi.nlm.nih.gov/pubmed/24482637
http://dx.doi.org/10.5114/aoms.2013.39617

Ejemplares similares